diethylnitrosamine has been researched along with morin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denda, A; Eimoto, H; Kinugasa, T; Kitazawa, S; Konishi, Y; Takashima, Y; Tsujiuchi, T; Tsutsumi, M; Ura, H | 1 |
| Niranjali Devaraj, S; Praveen Kumar, VR; Shilpa, PN; Sivaramakrishnan, V | 1 |
| Niranjali Devaraj, S; Sivaramakrishnan, V | 1 |
| Devaraj, SN; Sivaramakrishnan, V | 1 |
| Devaraj, H; MadanKumar, P; Manikandan, S; NaveenKumar, P; NiranjaliDevaraj, S | 1 |
| Halagowder, D; Perumal, M; Perumal, N; Sivasithamparam, N | 1 |
6 other study(ies) available for diethylnitrosamine and morin
| Article | Year |
|---|---|
Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis.
Topics: Acetophenones; Animals; Arachidonic Acid; Arachidonic Acids; Biomarkers, Tumor; Body Weight; Diethylnitrosamine; Ethoxyquin; Flavonoids; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Phenobarbital; Quercetin; Rats; Rats, Inbred F344; Tetradecanoylphorbol Acetate | 1989 |
Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin.
Topics: alpha-Fetoproteins; Animals; Antioxidants; Body Weight; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Diethylnitrosamine; Enzymes; Flavonoids; Hydroxyl Radical; Lipid Peroxides; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Rats; Rats, Wistar; Superoxide Dismutase | 2008 |
Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Hepatocellular; Cyclooxygenase 2; Diethylnitrosamine; Down-Regulation; Flavonoids; Liver Neoplasms, Experimental; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Rats; Rats, Wistar; Transcription Factor RelA; Tumor Cells, Cultured | 2009 |
Morin fosters apoptosis in experimental hepatocellular carcinogenesis model.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Binding Sites; Caspase 3; Caspase 9; Computer Simulation; Diethylnitrosamine; Flavonoids; G1 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Liver Neoplasms, Experimental; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; S Phase | 2010 |
Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling.
Topics: Animals; beta Catenin; Cell Line; Cell Proliferation; Cell Survival; Cyclin D1; Cytoprotection; Diethylnitrosamine; Dose-Response Relationship, Drug; Flavonoids; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatic Stellate Cells; Humans; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Oxidative Stress; Rats; Rats, Wistar; Time Factors; Wnt Signaling Pathway | 2014 |
Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Topics: Animals; Apoptosis Regulatory Proteins; Diethylnitrosamine; Flavonoids; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1; YAP-Signaling Proteins | 2017 |